THCv

Beyond appetite suppression, Tetrahydrocannabivarin (THCV) is a potent neuroprotectant and metabolic regulator. Its unique propyl side chain allows it to modulate the endocannabinoid system without typical impairment. Clinical research suggests it improves glycemic control and insulin sensitivity in Type 2 diabetics. Furthermore, its ability to reduce muscle tremors and inflammation shows significant promise for Parkinson’s disease and epilepsy, offering a clear-headed therapeutic alternative for complex neurological and metabolic conditions.